These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9681086)

  • 1. Veno-occlusive disease of the liver induced by gemcitabine.
    Dobbie M; Hofer S; Oberholzer M; Herrmann R
    Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.
    Vansteenkiste JF; Bomans P; Verbeken EK; Nackaerts KL; Demedts MG
    Lung Cancer; 2001 Jan; 31(1):83-5. PubMed ID: 11162870
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemolytic-uremic syndrome caused by gemcitabine.
    Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
    Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
    [No Abstract]   [Full Text] [Related]  

  • 4. Gemcitabine for lung cancer.
    Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
    [No Abstract]   [Full Text] [Related]  

  • 5. Gemcitabine and vascular toxicity.
    Muñoz A; Mañé JM; Rubio I; Fernández R; Fuente N; Barceló R; López Vivanco G
    Lung Cancer; 2002 Aug; 37(2):229. PubMed ID: 12140148
    [No Abstract]   [Full Text] [Related]  

  • 6. An unusual case of gemcitabine-induced radiation recall.
    Squire S; Chan M; Feller E; Mega A; Gold R
    Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
    [No Abstract]   [Full Text] [Related]  

  • 7. A fatal case of cholestatic liver failure probably related to gemcitabine.
    Coeman DC; Verbeken EK; Nackaerts KL; Demedts MG; Vansteenkiste JF
    Ann Oncol; 2000 Nov; 11(11):1503. PubMed ID: 11142494
    [No Abstract]   [Full Text] [Related]  

  • 8. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
    Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe interstitial pneumonitis related to Gemcitabine].
    Sabria-Trias J; Bonnaud F; Sioniac M
    Rev Mal Respir; 2002 Oct; 19(5 Pt 1):645-7. PubMed ID: 12473953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.
    Banach MJ; Williams GA
    Arch Ophthalmol; 2000 May; 118(5):726-7. PubMed ID: 10815173
    [No Abstract]   [Full Text] [Related]  

  • 11. Gemcitabine--a major advance?
    Thomas A; Steward WP
    Ann Oncol; 1998 Dec; 9(12):1265-7. PubMed ID: 9932153
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasculitis due to gemcitabine.
    Voorburg AM; van Beek FT; Slee PH; Seldenrijk CA; Schramel FM
    Lung Cancer; 2002 May; 36(2):203-5. PubMed ID: 11955656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine-associated autonomic neuropathy.
    Dormann AJ; Grünewald T; Wigginghaus B; Huchzermeyer H
    Lancet; 1998 Feb; 351(9103):644. PubMed ID: 9500323
    [No Abstract]   [Full Text] [Related]  

  • 14. Maculopapular rashes secondary to gemcitabine injection for non-small-cell lung cancer.
    Chen YM; Liu JM; Tsai CM; Whang-Peng J; Perng RP
    J Clin Oncol; 1996 May; 14(5):1743-4. PubMed ID: 8622097
    [No Abstract]   [Full Text] [Related]  

  • 15. [The medical treatment of advanced non-small-cell lung carcinoma (adv NSCLC). The correlation with multidimensional assessment].
    Guidi F; Paggi P; Lo Nardo D; Gattafoni P; Consales D
    Minerva Med; 1999; 90(7-8):210-3. PubMed ID: 10719420
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II study of gemcitabine (2',2'-difluorodeoxycytidine) given as a twice weekly schedule to previously untreated patients with non-small cell lung cancer.
    Lund B; Ryberg M; Petersen PM; Anderson H; Thatcher N; Dombernowsky P
    Ann Oncol; 1994 Nov; 5(9):852-3. PubMed ID: 7848889
    [No Abstract]   [Full Text] [Related]  

  • 17. Digital ischemic changes after gemcitabine therapy in a patient with metastatic non-small-cell lung cancer.
    Yildiz R; Coskun U; Kaya AO; Ozturk B; Yaman E
    Ann Pharmacother; 2007 May; 41(5):901-2. PubMed ID: 17405819
    [No Abstract]   [Full Text] [Related]  

  • 18. [First-line non-small-cell lung cancer: role of gemcitabine].
    Barata F
    Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S20-2. PubMed ID: 16273006
    [No Abstract]   [Full Text] [Related]  

  • 19. Metastatic non-small-cell lung cancer and the use of gemcitabine during pregnancy.
    Gurumurthy M; Koh P; Singh R; Bhide A; Satodia P; Hocking M; Anbarasu A; Wood LE
    J Perinatol; 2009 Jan; 29(1):63-5. PubMed ID: 19112460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemcitabine-induced hemolytic uremic syndrome: a case report.
    Brodowicz T; Breiteneder S; Wiltschke C; Zielinski CC
    J Natl Cancer Inst; 1997 Dec; 89(24):1895-6. PubMed ID: 9414181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.